Clinical Trial Update: A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of combining hydroxyurea with valproic acid or 6-mercaptopurine with valproic acid in adults with unfit a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• 6-mercaptopurine (6-mercaptopurine)
• HYDROXYUREA (Hydroxyurea)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes, Adult | Phase 1, Phase 2 | Status: RECRUITING